Table 1 The main demographic, laboratory findings, and clinical characteristics of subjects
Variables | BD patients (n = 205) | Control (n = 207) |
|---|---|---|
Age (years) | 36 ± 0.72 | 37 ± 0.4 |
Male/ Female | 89 (43.4%)/ 116 (56.6%) | 100 (48.3%)/ 107 (51.7%) |
Age of onset (year) | 30.8 ± 0.8 | - |
Family history of BD | 37 (18.04%) | - |
Family history of others | 39 (19.02%) | - |
Autoimmune disease | - | |
Smoking | 37 (18.04%) | |
Positive pathergy test | 56 (27.31%) | - |
HLA-B27 positive | 8 (3.9%) | - |
HLA-B51 positive | 31 (15.12%) | - |
Oral aphthous | 177 (86.34%) | - |
Genital aphthous | 105 (51.12%) | - |
Skin manifestations | 86 (41.95) | - |
Eye manifestations | 67 (32.68%) | - |
Joint manifestations | 111 (54.14%) | - |
Neural manifestations | 53 (25.85%) | - |
Vascular manifestations | 13 (6.34%) | - |
Cardiac involvement | 11 (5.36%) | - |
Lung involvement | 6 (2.92%) | - |
Renal involvement | 18 (8.78%) | - |
Gastrointestinal involvement | 17 (8.29%) | - |
WBC (Cells/mm3, Mean ± SD) | 7693.8 ± 597.13 | - |
CRP positive (>6 mg/L) | 27 (13.17%) | |
ESR (mm, Mean ± SD) | 15.3 ± 1.2 | - |